Pharmasset (VRUS) Downgraded by Analysts

Pharmasset (NASDAQ: VRUS) was downgraded by numerous analysts.

Pharmasset (VRUS) was downgraded by Noble Financial to a “Sell” rating.

Pharmasset was downgraded by William Blair to a “Market Perform” rating.

Pharmasset was downgraded by Brean Murray from a “Buy” rating to a “Hold” rating.

Pharmasset was downgraded by Wells Fargo & Co. (NYSE:WFC) from an “Outperform” rating to a “Market Perform” rating.

Pharmasset was downgraded by JPMorgan Chase & Co. (NYSE:JPMN) from an “Overweight” rating to a “Neutral” rating. They have a price target of $137.00 on the company.

Pharmasset was downgraded by Canaccord Genuity from a “Buy” rating to a “Hold” rating.

Pharmasset was downgraded by Leerink from an “Outperform” rating to a “Market Perform” rating.

Pharmasset was downgraded by UBS AG (NYSE:UBS) from a “Buy” rating to a “Neutral” rating.